
About Brainsway
Brainsway (TLV:BWAY), (NASDAQ:BWAY) specializes in the development and marketing of advanced neurostimulation treatments for mental health disorders. The company's main focus is on its patented Deep Transcranial Magnetic Stimulation (Deep TMS) technology, a non-invasive treatment designed to target areas of the brain associated with mood and behavior disorders. Brainsway aims to improve the well-being of patients suffering from a variety of mental health conditions, including major depressive disorder, obsessive-compulsive disorder, and smoking addiction, among others. Through continuous research and development, Brainsway strives to expand the applications of Deep TMS technology to address a wider range of neurological and psychiatric disorders, working towards the objective of offering effective, accessible, and safe treatment alternatives for patients worldwide.
Snapshot
Operations
Produtos e/ou serviços de Brainsway
- Deep TMS Therapy - A non-invasive treatment for depression and OCD using magnetic fields to stimulate brain regions.
- Smoking Cessation - TMS technology aimed at helping individuals quit smoking.
- Obsessive-Compulsive Disorder Treatment - Offering a specialized TMS coil designed for patients with OCD.
- Alzheimer's Disease Management - Developing TMS solutions to alleviate symptoms of Alzheimer's disease.
- Anxiety Disorder Treatment - Utilizing TMS to reduce symptoms of various anxiety disorders.
- Bipolar Depression Treatment - Tailored TMS protocols to address the depressive phase in bipolar disorder patients.
equipe executiva do Brainsway
- Mr. Hadar LevyChief Executive Officer
- Dr. David Zacut M.D.Co-Founder & Vice-Chairman
- Mr. Avner HagaiFounder & Director
- Prof. Abraham Zangen Ph.D.Co-Founder, Member of Scientific Advisory Board & Director
- Mr. Ido MaromChief Financial Officer
- Dr. Colleen Hanlon Ph.D.Vice President of Medical Affairs
- Mr. Michael CohenVice President of US Sales
- Dr. Yiftach Roth Ph.D.Founder & Chief Scientific Officer
- Mr. Dor HagaiVice President of Operations
- Mr. Gilead Moiseyev Ph.D.Chief Technology Officer